Ruxotor 10 mg (Ruxolitinib) Tablets

Ruxotór 10 should be taken exactly according to the prescription of a qualified healthcare professional. The appropriate dose depends on the indication, blood-cell counts, treatment response, and individual patient factors.

Standard Adult Dosing

• Myelofibrosis: The starting dose is generally selected according to the patient's platelet count and clinical condition; commonly used starting doses include 5 mg, 10 mg, 15 mg, or 20 mg twice daily.
• Polycythemia Vera: A commonly recommended starting regimen is 10 mg twice daily, with subsequent adjustment based on response and safety.
• Graft-Versus-Host Disease: Dosing varies according to the patient's age, indication, and treatment setting and should follow the specialist's prescription.

How to Take

• Take the tablet orally with water.
• It may generally be taken with or without food.
• Take doses at approximately the same times each day.
• Do not change the dose or stop treatment without medical advice.
• Regular blood tests may be required during treatment to monitor blood-cell counts and other safety parameters.

Missed Dose

If a dose is missed, take the next scheduled dose at the usual time. Do not take an extra dose to compensate for a missed dose.

Important

Ruxolitinib dosing may need adjustment when blood counts fall, during certain infections, or in patients with kidney or liver impairment. Dose changes should only be made by the prescribing physician.